• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients.

作者信息

Somerville T, Hurst G, Alloway R, Gaber A, Shokouh-Amiri M H, Stratta R

机构信息

University of Tennessee College of Pharmacy and Medicine, Memphis, USA.

出版信息

Transplant Proc. 1998 Jun;30(4):1546-8. doi: 10.1016/s0041-1345(98)00352-2.

DOI:10.1016/s0041-1345(98)00352-2
PMID:9636628
Abstract
摘要

相似文献

1
Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients.口服更昔洛韦在预防肾胰腺联合移植受者及单纯胰腺移植受者巨细胞病毒感染方面比口服阿昔洛韦疗效更佳。
Transplant Proc. 1998 Jun;30(4):1546-8. doi: 10.1016/s0041-1345(98)00352-2.
2
Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation.在肾移植和肾/胰腺移植中使用大剂量阿昔洛韦和靶向静脉注射更昔洛韦根除巨细胞病毒再激活疾病
Transplantation. 1997 Sep 27;64(6):931-3. doi: 10.1097/00007890-199709270-00026.
3
Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.重新评估巨细胞病毒感染在肾移植和肾胰联合移植中的影响。
Am J Kidney Dis. 2002 May;39(5):1088-95. doi: 10.1053/ajkd.2002.32793.
4
A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.口服阿昔洛韦与口服更昔洛韦用于高危肾移植受者巨细胞病毒预防的随机前瞻性对照试验。
Transplantation. 1998 Dec 27;66(12):1682-8. doi: 10.1097/00007890-199812270-00019.
5
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.口服更昔洛韦或口服阿昔洛韦预防器官移植受者原发性巨细胞病毒病
Transpl Infect Dis. 2000 Sep;2(3):112-7.
6
A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.口服更昔洛韦与口服伐昔洛韦预防肾移植后巨细胞病毒病的随机前瞻性对照试验。
Transpl Int. 2002 Dec;15(12):615-22. doi: 10.1007/s00147-002-0475-0. Epub 2002 Nov 5.
7
Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits.
Transplant Proc. 1998 Aug;30(5):2094. doi: 10.1016/s0041-1345(98)00549-1.
8
Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation.
Transplant Proc. 2001 Nov-Dec;33(7-8):3621-3. doi: 10.1016/s0041-1345(01)02558-1.
9
Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children.静脉注射更昔洛韦后口服阿昔洛韦与单纯静脉注射更昔洛韦预防儿童肝移植后巨细胞病毒和EB病毒疾病的比较。
Clin Infect Dis. 1997 Dec;25(6):1344-9. doi: 10.1086/516139.
10
Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
Transplant Proc. 1996 Oct;28(5):2811.

引用本文的文献

1
Viral prophylaxis in organ transplant patients.器官移植患者的病毒预防
Drugs. 2004;64(24):2763-92. doi: 10.2165/00003495-200464240-00004.
2
Lessons learned from more than 1,000 pancreas transplants at a single institution.从一家机构进行的1000多例胰腺移植中吸取的经验教训。
Ann Surg. 2001 Apr;233(4):463-501. doi: 10.1097/00000658-200104000-00003.
3
Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction.胰腺移植技术的进展：采用门静脉-肠道引流且无抗淋巴细胞诱导的同期肾-胰腺移植
Ann Surg. 1999 May;229(5):701-8; discussion 709-12. doi: 10.1097/00000658-199905000-00013.